
The company is expanding in Texas despite legislative resistance to augment the state's medical program.
The company is expanding in Texas despite legislative resistance to augment the state's medical program.
The company has forecasted $80 million in revenue for 2023.
The board approved a one-time grant of performance shares to certain members of the management team.
The firm's first quarter ended with a net loss of $28 million.
iAnthus is grappling with several legal battles that pose risks to its operational future.
Cost cuts include a 46.6% drop in labor-related expenses and a 34.5% reduction in general and administrative expenses.
Restructuring initiatives included cutting its workforce in Israel by 21% across all functions.
No updates were provided on the timing for sale close.
There was a 57.7% improvement in the adjusted EBITDA loss over the year.
The company's net loss ticked down after March labor cuts.
Unpack the industry with the daily cannabis newsletter for business leaders.
Unpack the industry with the daily cannabis newsletter for business leaders.